0001567619-21-022541.txt : 20211227 0001567619-21-022541.hdr.sgml : 20211227 20211227200936 ACCESSION NUMBER: 0001567619-21-022541 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211222 FILED AS OF DATE: 20211227 DATE AS OF CHANGE: 20211227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TREACE JAMES T CENTRAL INDEX KEY: 0001185191 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40355 FILM NUMBER: 211521894 MAIL ADDRESS: STREET 1: 117 BRISTOL PLACE CITY: PONTE VEDRA BEACH STATE: FL ZIP: 32082 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TREACE MEDICAL CONCEPTS, INC. CENTRAL INDEX KEY: 0001630627 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 471052611 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 203 FORT WADE ROAD STREET 2: SUITE 150 CITY: PONTE VEDRA STATE: FL ZIP: 32081 BUSINESS PHONE: (904) 373-5940 MAIL ADDRESS: STREET 1: 203 FORT WADE ROAD STREET 2: SUITE 150 CITY: PONTE VEDRA STATE: FL ZIP: 32081 4 1 doc1.xml FORM 4 X0306 4 2021-12-22 0 0001630627 TREACE MEDICAL CONCEPTS, INC. TMCI 0001185191 TREACE JAMES T C/O TREACE MEDICAL CONCEPTS, INC. 203 FORT WADE ROAD, SUITE 150 PONTE VEDRA FL 32081 1 0 0 0 Common Stock 2021-12-22 4 S 0 23390 16.2764 D 20612 I By J&A Group LLC Common Stock 2021-12-23 4 S 0 12610 16.9040 D 8002 I By J&A Group LLC Common Stock 2021-12-27 4 S 0 6437 17.4581 D 1565 I By J&A Group LLC Common Stock 1006183 I By spouse Common Stock 1461441 D Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.59 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.50 to $17.29 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.25 to $17.615 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Lisa Taylor as Attorney-in-fact for James T. Treace 2021-12-27